News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
79 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
Mr. Rasschaert will be responsible for overseeing sales of the Company’s FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal to hospitals and medical centers across Europe.
January 26, 2018
·
7 min read
ASIT Biotech Successfully Completes the First Tranche if its Capital Increase and Raises €9.4 Million
A second subscription phase is currently taking place, and the Company has every hope it will obtain a swift subscription of the remaining €2 million of shares that can still be subscribed to on the basis of the approval granted by the Shareholders Meeting on 7 December.
January 26, 2018
·
2 min read
Policy
Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics
The US Patent and Trademark Office previously upheld the validity of the patents rejecting multiple challenges filed by Ariosa.
January 26, 2018
·
1 min read
Biotech Bay
Rigel Pharma, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(C)(4)
Rigel Pharma today announced that on January 15, 2018 and January 24, 2018 the Compensation Committee of Rigel’s Board of Directors approved the grants of inducement stock options to purchase an aggregate of 48,000 shares of common stock to three new employees.
January 26, 2018
·
2 min read
BioMidwest
Sensient Announces Conference Call on February 9, 2018
Sensient Technologies Corporation will hold its conference call to discuss 2017 fourth quarter and year end results at 10:00 a.m. CST on Friday, February 9, 2018.
January 26, 2018
·
1 min read
BioMidwest
Sensient Declares Dividend
The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.33 per share.
January 26, 2018
·
1 min read
Primus Announces a Voluntary Nationwide Recall of All Lots Within Expiry of Prescription Medical Food Limbrel Due to Rare But Serious and Reversible Adverse Events
Primus is notifying its distributors by emailed letter and is arranging for the return of all recalled products.
January 26, 2018
·
4 min read
Deals
CASI Pharma Acquires ANDA Portfolio From Sandoz
CASI intends to select and commercialize certain products from the portfolio that have unique market opportunity and cost-effective manufacturing in China and/or in the U.S.
January 26, 2018
·
5 min read
Biotech Beach
Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock
Innovus Pharmaceuticals announces that it was made aware of and requested by the OTC Markets Group Inc. to comment on recent market activity concerning shares of INNV common stock.
January 26, 2018
·
5 min read
Previous
8 of 8